RxDoctor Payments Data

Alex Levin, MD

Ophthalmology · Rochester, NYNPI 1750530382

Payments from drug & device makers

$36,674in general payments, 2019–2025

Across 18 payments — averaging $2037.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$24K
  • Travere Therapeutics, Inc.$5K
  • Johnson & Johnson$4K
  • Tanabe Pharma America, Inc.$4K
  • Abiomed$165
  • Janssen Global Services, LLC$114

What the payments were for

  • Consulting fees$7,97397%
  • Food & beverage$2793%

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$36,674 in reported general payments places this provider in the 90th percentile of 1,587 ophthalmology providers in New York.

See all ophthalmology providers in New York

Medicare billing

Part B allowed, 2024
$4,023
Medicare patients
19
Services billed
62

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Acetazolamide ErAcetazolamide11$696
Dorzolamide Hcl24$414

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Rochester

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →